BostonGene’s Foundation Model of Cancer and the Immune System–Led Approach Recognized for Advancing Precision Oncology and De-Risking Drug Development for BiopharmaWALTHAM, Mass.--(BUSINESS ...
What happens when pharma and flow cores face the same challenge — doing more with less?​ Join Ryan Duggan (AbbVie) and David ...
The research antibodies market offers opportunities in personalized medicine, boosted by advancements in genomics and proteomics, and rising infectious and chronic disease rates. Key growth areas ...